Sanofi inks deal with I-Mab; Wave discloses $175M offering on heels of DMD data

Plus, news about BioAge, Fulcrum Therapeutics and Arcutis Biotherapeutics:

Sanofi snags Greater China rights to CD73 antibody: The French pharma

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

New DNA-based anticoagulant could treat heparin-induced thrombocytopenia

Various medical circumstances, including heart attacks and extreme cases of COVID-19, necessitate the use of anticoagulants, medicines that prevent blood clots

August 21, 2023

FDA chief scientist to replace Woodcock

WASHINGTON — The Food and Drug Administration’s chief scientist will replace retiring Janet Woodcock as principal deputy commissioner of the agency next year, the FDA commissioner

November 29, 2023

Study reveals limited access to pulmonary rehabilitation for millions of Americans

Pulmonary rehabilitation, an essential component of care for patients with chronic respiratory conditions, is difficult for millions of Americans to access, a new Yale-led study

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.